Target intelligence / Profile preview

MicroRNA 519e (miR-519e)

Target
miR-519e
Molecular classification
MicroRNA, Non-coding RNA, C19MC cluster member
01

Overview

MicroRNA 519e (miR-519e) is a small, non-coding RNA molecule encoded within the large, primate-specific C19MC microRNA cluster located on chromosome 19q13.42[1]. Like other microRNAs, miR-519e regulates gene expression post-transcriptionally by binding to complementary mRNA sequences, resulting in gene silencing or degradation[3]. Members of the C19MC family, including miR-519e, are minimally expressed in differentiated tissues but can be highly upregulated in certain cancers, such as hepatocellular carcinoma, where they contribute to oncogenesis by promoting cell proliferation, migration, and invasion[1]. They also appear to be regulated by epigenetic mechanisms, including methylation[1]. The unique expression patterns and oncogenic functions of miR-519e make it a candidate biomarker for certain cancer subtypes[1], although it is not currently directly targeted by approved therapeutic agents.

Other names
hsa-mir-519eMIR519EMIRN519E
02

Mechanism of action

MicroRNAs act by binding to complementary sequences on target messenger RNAs (mRNAs), leading to their degradation or inhibition of translation, thereby downregulating gene expression[1][3]. For miR-519e specifically, as a member of the C19MC cluster, its upregulation is associated with increased cell proliferation, migration, and invasion, particularly in hepatocellular carcinoma[1].

03

Biological functions

Post-transcriptional gene regulationCell proliferationCell differentiation (inferred by family function)Potential cell migration and invasion (supported by C19MC cluster functions[1])
04

Disease associations

Cancer (oncogenic role, especially in hepatocellular carcinoma within the C19MC cluster[1])Other diseases: Not broadly documented outside cancer contexts
05

Safety considerations

Therapeutic targeting of miR-519e presents potential concerns related to off-target effects and the broader roles of microRNAs in essential gene regulatory networks; specific safety concerns for miR-519e-targeted agents are not described in the available literature.
06

Biomarkers

miR-519e expression may serve as a biomarker for hepatocellular carcinoma subtypes, particularly in identifying the C2 subclass associated with poor prognosis and aggressive behavior[1]

Beyond the preview

Go deeper on MicroRNA 519e (miR-519e).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 519e (miR-519e).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call